NEW YORK (GenomeWeb News) - Genomic Health plans to sell 3 million shares of its common stock through an underwritten public offering, the company said yesterday.
 
The company said it will use the proceeds from the sale for general corporate purposes, marketing, R&D, and for expanding its labs.
 
Genomic Health said it will grant underwriters a 30-day option to buy an additional 450,000 shares.
 
The company's stock closed at $15.79 on Monday.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.